| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Amiodarone | FAERS: 4 | US FAERS | |
| 2 | Digoxin | FAERS: 2 | US FAERS | |
| 3 | rofecoxib | FAERS: 2 | US FAERS | |
| 4 | Cilostazol | FAERS: 1 | US FAERS | |
| 5 | Dexamethasone | FAERS: 1 | US FAERS | |
| 6 | Vardenafil Dihydrochloride | FAERS: 1 | US FAERS | |
| 7 | Amiodarone | OFFSIDES | ||
| 8 | Carvedilol | OFFSIDES | ||
| 9 | Eplerenone | OFFSIDES | ||
| 10 | Fondaparinux | OFFSIDES | ||
| 11 | Irinotecan | OFFSIDES | ||
| 12 | Milrinone | OFFSIDES | ||
| 13 | Mometasone Furoate | OFFSIDES | ||
| 14 | NuvaRing | OFFSIDES | ||
| 15 | Pioglitazone | OFFSIDES | ||
| 16 | Triiodothyronine | OFFSIDES | ||
| 17 | carbidopa, levodopa drug combination | OFFSIDES | ||
| 18 | dofetilide | OFFSIDES | ||
| 19 | entacapone | OFFSIDES | ||
| 20 | valdecoxib | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.